| |
| |
|
| Insider
Information: |
Quinlan Paul T |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
218,403 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
218,403 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
TerraVia Holdings Inc |
TVIA |
General Counsel |
2017-03-09 |
218,403 |
|
0 |
Premium* |
|
|
Cymabay Therapeutics, Inc. |
CBAY |
|
2024-03-22 |
0 |
2023-05-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
91 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TVIA |
TerraVia Holdings Inc |
General Counsel |
• – – |
2014-07-21 |
4 |
OE |
$2.35 |
$14,100 |
D/D |
6,000 |
92,875 |
0 |
- |
|
| TVIA |
TerraVia Holdings Inc |
General Counsel |
• – – |
2014-07-21 |
4 |
AS |
$9.80 |
$58,777 |
D/D |
(6,000) |
86,875 |
0 |
- |
|
| TVIA |
TerraVia Holdings Inc |
General Counsel |
• – – |
2014-08-15 |
4 |
AS |
$9.13 |
$22,834 |
D/D |
(2,500) |
86,875 |
0 |
- |
|
| TVIA |
TerraVia Holdings Inc |
General Counsel |
• – – |
2014-08-19 |
4 |
AS |
$9.55 |
$57,281 |
D/D |
(6,000) |
86,875 |
0 |
- |
|
| TVIA |
TerraVia Holdings Inc |
General Counsel |
• – – |
2014-08-19 |
4 |
OE |
$2.35 |
$14,100 |
D/D |
6,000 |
92,875 |
0 |
- |
|
| TVIA |
TerraVia Holdings Inc |
General Counsel |
• – – |
2014-09-09 |
4 |
AS |
$8.53 |
$141,237 |
D/D |
(16,562) |
70,313 |
0 |
- |
|
| TVIA |
TerraVia Holdings Inc |
General Counsel |
• – – |
2015-03-02 |
4 |
D |
$2.67 |
$15,344 |
D/D |
(5,747) |
64,566 |
0 |
- |
|
| TVIA |
TerraVia Holdings Inc |
General Counsel |
• – – |
2015-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
89,566 |
0 |
- |
|
| TVIA |
TerraVia Holdings Inc |
General Counsel |
• – – |
2015-03-09 |
4 |
AS |
$2.69 |
$26,098 |
D/D |
(9,687) |
79,879 |
0 |
- |
|
| TVIA |
TerraVia Holdings Inc |
General Counsel |
• – – |
2015-09-15 |
4 |
AS |
$3.08 |
$4,814 |
D/D |
(1,562) |
78,317 |
0 |
- |
|
| TVIA |
TerraVia Holdings Inc |
General Counsel |
• – – |
2015-09-17 |
4 |
AS |
$3.14 |
$4,911 |
D/D |
(1,562) |
76,755 |
0 |
- |
|
| TVIA |
TerraVia Holdings Inc |
General Counsel |
• – – |
2016-03-08 |
4 |
AS |
$1.66 |
$2,600 |
D/D |
(1,562) |
75,193 |
0 |
- |
|
| TVIA |
TerraVia Holdings Inc |
General Counsel |
• – – |
2016-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
62,500 |
137,693 |
0 |
- |
|
| TVIA |
TerraVia Holdings Inc |
General Counsel |
• – – |
2016-03-10 |
4 |
AS |
$1.64 |
$7,666 |
D/D |
(4,686) |
133,007 |
0 |
- |
|
| TVIA |
TerraVia Holdings Inc |
General Counsel |
• – – |
2016-09-13 |
4 |
AS |
$2.74 |
$4,273 |
D/D |
(1,562) |
133,652 |
0 |
- |
|
| TVIA |
TerraVia Holdings Inc |
General Counsel |
• – – |
2016-09-16 |
4 |
AS |
$2.60 |
$8,127 |
D/D |
(3,124) |
130,528 |
0 |
- |
|
| TVIA |
TerraVia Holdings Inc |
General Counsel |
• – – |
2016-10-14 |
4 |
AS |
$2.55 |
$25,528 |
D/D |
(10,000) |
120,403 |
0 |
- |
|
| TVIA |
TerraVia Holdings Inc |
General Counsel |
• – – |
2017-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
123,000 |
243,403 |
0 |
- |
|
| TVIA |
TerraVia Holdings Inc |
General Counsel |
• – – |
2017-03-09 |
4 |
AS |
$0.81 |
$20,233 |
D/D |
(25,000) |
218,403 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
General Counsel |
• – – |
2023-05-15 |
4 |
OE |
$2.94 |
$14,700 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
General Counsel |
• – – |
2023-05-15 |
4 |
AS |
$10.37 |
$51,831 |
D/D |
(5,000) |
0 |
0 |
% |
|
| CBAY |
Cymabay Therapeutics, Inc... |
General Counsel |
• – – |
2023-06-30 |
4 |
AS |
$10.05 |
$50,250 |
D/D |
(5,000) |
0 |
0 |
% |
|
| CBAY |
Cymabay Therapeutics, Inc... |
General Counsel |
• – – |
2023-06-30 |
4 |
OE |
$2.94 |
$14,700 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
General Counsel |
• – – |
2023-07-14 |
4 |
OE |
$2.94 |
$14,700 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
General Counsel |
• – – |
2023-07-14 |
4 |
AS |
$11.81 |
$59,050 |
D/D |
(5,000) |
0 |
0 |
% |
|
91 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
